Company: DMAAR
Filing Date: 2025-03-31
Form Type: 10-K
Source: 0001213900-25-026240
Chunk: 295

Company: Drugs Made In America Acquisition Corp.
Filing Date: 2025-03-31
Form: 10-K
Item: Item 2
Chunk 295
---
 Glenn Worman
     
    (Principal Financial and Accounting Officer)

    /s/ Catherine Do
     
    Director
     
    March 31, 2025
  
    Catherine Do

    /s/ G. Sridhar Prasad
     
    Director
     
    March 31, 2025
  
    G. Sridhar Prasad

    /s/ Myron W. Shulgan
     
    Director
     
    March 31, 2025
  
    Myron W. Shulgan

29

DRUGS MADE IN AMERICA ACQUISITION CORP.

INDEX TO FINANCIAL STATEMENTS

  Report of Independent Registered Public Accounting Firm (PCAOB ID: 206)   F-2  Financial Statements:      Balance Sheet as of December 31, 2024   F-3  Statement of Operations for the Period from May 23, 2024 (inception) through December 31, 2024   F-4  Statement of Changes in Shareholders’ Deficit for the Period from May 23, 2024 (inception) through December 31, 2024   F-5  Statement of Cash Flows for the Period from May 23, 2024 (inception) through December 31, 2024   F-6  Notes to Financial Statements   F-7 to F-16 

F-1

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING
FIRM

To the Shareholders and Board of Directors of

Drugs Made In America Acquisition Corp.

Opinion on the Financial Statements

We have audited the accompanying balance sheet of Drugs Made In America
Acquisition Corp (the “Company”) as of December 31, 2024, and the related statements of operations, changes in shareholders’
deficit, and cash flows for the period from May 23, 2024 (inception) through December 31, 2024, and the related notes (collectively referred
to as the “financial statements”). In our opinion, the financial statements presents fairly, in all material respects, the
financial position of the Company as of December 31, 2024, and the results of its operations and its cash flows the period from May 23,
2024 (inception) through December 31, 2024, in conformity with accounting principles generally accepted in the United States of America.

Going Concern Matter

The